Inflammatory Bowel Diseases: From Bench to Bedside : Proceedings of the Falk Symposium No. 96 (Part IV of the Gastroenterology Symposia 1996) Held in Freiburg-im-Breisgau, Germany, October 30-November 1, 1996T. Andus |
From inside the book
Results 1-3 of 85
Page 65
... effect for Crohn's disease ? The potential pathogenetic mechanism to explain the effect of smoking in Crohn's disease has also been investigated . One could postulate that an increase in permeability might allow more ' toxins ' to cross ...
... effect for Crohn's disease ? The potential pathogenetic mechanism to explain the effect of smoking in Crohn's disease has also been investigated . One could postulate that an increase in permeability might allow more ' toxins ' to cross ...
Page 149
... effect of the SP antagonist was restricted to toxin A - induced enterocolitis since the secretory effects of cholera ... effect . This effect was also dependent on the presence of lymphocytes since no increase in SP was seen in athymic ...
... effect of the SP antagonist was restricted to toxin A - induced enterocolitis since the secretory effects of cholera ... effect . This effect was also dependent on the presence of lymphocytes since no increase in SP was seen in athymic ...
Page 170
... effect and may actually have a deleterious effect . This may result from the auto - inhibition of nicotine receptors at high dosage . Attenuation of sympathetic input to the gut may also modulate inflammation . In the nematode ...
... effect and may actually have a deleterious effect . This may result from the auto - inhibition of nicotine receptors at high dosage . Attenuation of sympathetic input to the gut may also modulate inflammation . In the nematode ...
Contents
new data | 5 |
Current and future parameters for stratification | 13 |
Genetic and chemical models of inflammatory bowel | 21 |
Copyright | |
44 other sections not shown
Common terms and phrases
acid active Crohn's disease acute adhesion molecules antibody antigens associated azathioprine bacterial budesonide cancer CD4+ T cells chronic Clin clinical colectomy colitis and Crohn's collagen colonic controlled trial corticosteroids Crohn's disease cyclosporine cytokines disease activity dose drugs dysplasia effect elemental diet endoscopic enemas expression fibroblasts fistulae function Gastroenterol Gastroenterology gastrointestinal gene genetic growth factor human IFN-y ileal ileostomy ileum immune Immunol increased induced inflammation inflammatory bowel disease inhibition integrins interleukin intestinal epithelial cells intestinal inflammation lamina propria lesions levels lymphocytes macrophages mast cells measles mediators mesalazine metabolism metronidazole mice mucosal normal oral pathogenesis patients with Crohn's patients with inflammatory patients with ulcerative peptide placebo pouch pouchitis prednisolone proctocolectomy production protein recent receptor recurrence relapse remission resection response risk role short bowel syndrome small bowel small intestine steroid stimulation studies sulphasalazine surgery therapeutic therapy tissue TNF-a treatment tumor necrosis ulcerative colitis